Similar to Emran et al. and Song et al., another recent study by Guler et al. also observed IFN pathway enrichment in DTPs derived from the EGFR mutant NSCLC cell line PC9 [14]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.